Sodium Iodide → Ziprasidone

HRID 1925221

반응식

HRID 1925221 반응식
[CH:1]1[CH:2]=[CH:3][C:4]2[S:9][N:8]=[C:7]([N:10]3[CH2:15][CH2:14][N:13]([CH2:16][CH2:17][C:18]4[CH:19]=[C:20]5[CH2:28][C:26](=[O:27])[NH:25][C:21]5=[CH:22][C:23]=4[Cl:24])[CH2:12][CH2:11]3)[C:5]=2[CH:6]=1.Cl.S1C2C=CC=CC=2C(N2CCNCC2)=N1.ClCCC1C=C2C(=CC=1Cl)NC(=O)C2.[I-].[Na+].C(=O)([O-])[O-].[Na+].[Na+]>C(C(C)=O)C(C)C>[CH:1]1[CH:2]=[CH:3][C:4]2[S:9][N:8]=[C:7]([N:10]3[CH2:11][CH2:12][N:13]([CH2:16][CH2:17][C:18]4[CH:19]=[C:20]5[CH2:28][C:26](=[O:27])[NH:25][C:21]5=[CH:22][C:23]=4[Cl:24])[CH2:14][CH2:15]3)[C:5]=2[CH:6]=1

참가 물질

7

반응물 5

HCID 5238Sodium IodideHCID 10340Sodium CarbonateHCID 219099Ziprasidone HydrochlorideHCID 27721443-(1-Piperazinyl)-1,2-benzisothiazoleHCID 106094745-(2-Chloroethyl)-6-chlorooxindole

생성물 1

HCID 60854Ziprasidone

시약·촉매·용매 1

HCID 7909Methyl Isobutyl Ketone용매

실험 절차

U.S. Pat. No. 4,831,031 discloses a process for the preparation of ziprasidone hydrochloride, which involves refluxing N-(1,2-benzisothiazol-3-yl)piperazine with 5-(2-chloroethyl)-6-chloro-oxindole in methyl isobutyl ketone in the presence of sodium iodide and sodium carbonate for about 40 hours followed by column chromatographic purification of the product to get ziprasidone base which is dissolved in methylene chloride and treated with ethereal hydrogen chloride to get ziprasidone hydrochloride salt. The salt is washed with acetone and the product is dried.

후처리

  1. customfollowed by column chromatographic purification of the product

출처 및 근거

ORD 기록
ord-a1fe5bcacab64580aac065d315eeeb4c
출처 데이터셋
uspto-grants-2012_05
특허 번호
US08178674B2

연결된 노트

불러오는 중…